openPR Logo
Press release

Neurovascular Embolization Devices Market Growing Rapidly by 2031- Stryker Corporation, Johnson & Johnson Inc., Terumo Corporation, B. Braun,, Melsungen AG, Integra LifeSciences Corporation

07-16-2024 07:29 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Neurovascular Embolization Devices Market Growing Rapidly

DataM Intelligence has published a new research report on "Neurovascular Embolization Devices Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/neurovascular-embolization-devices-market

The Neurovascular Embolization Devices market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.

Neurovascular embolization devices are medical tools used to treat abnormalities in the blood vessels of the brain and spine, such as aneurysms, arteriovenous malformations (AVMs), and fistulas. These devices, including coils, stents, and liquid embolic agents, are inserted via minimally invasive techniques to block abnormal blood flow or reinforce vessel walls. By occluding or diverting blood flow, neurovascular embolization devices help prevent ruptures and reduce the risk of stroke and other complications, providing a safer alternative to open surgery.

Forecast Growth Projected:

The Global Neurovascular Embolization Devices Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

List of the Key Players in the Neurovascular Embolization Devices Market:

Stryker Corporation, Johnson & Johnson Inc., Terumo Corporation, B. Braun,, Melsungen AG, Integra LifeSciences Corporation, Acandis GmBH, Phenox GmBH, Lepu Medical Technology (Beijing)Co, Shape Memory Medical Inc and Medtronic plc.

Segment Covered in the Neurovascular Embolization Devices Market:

By Product Type: Liquid Embolic Systems, Embolization Coils, Aneurysm Clips, Flow Diversion Stents, Others

By Treatment: Oral Ischemic Stroke Solutions, Hemorrhagic Stroke Solutions

By Indicatio: Infants Brain aneurysm, Arteriovenous malformations, Others

By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Academic Research Centers, Others

Regional Analysis:

The global Neurovascular Embolization Devices Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/neurovascular-embolization-devices-market

Regional Analysis:

The global Neurovascular Embolization Devices Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Neurovascular Embolization Devices Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Neurovascular Embolization Devices manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Neurovascular Embolization Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Get a Free Sample PDF copy of the report @ https://datamintelligence.com/download-sample/neurovascular-embolization-devices-market

FAQs

How big is the Neurovascular Embolization Devices Market?

The Neurovascular Embolization Devices Market size was USD $ 3.7 billion in 2023. It is expected to reach USD $ 6.0 billion by 2031.

How fast is the Neurovascular Embolization Devices Market growing?

The Neurovascular Embolization Devices Market will exhibit a CAGR of 6.4% during the forecast period, 2024-2031.

Read Latest Blog: https://www.datamintelligence.com/blogs/top-10-process-automation-companies-worldwide

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurovascular Embolization Devices Market Growing Rapidly by 2031- Stryker Corporation, Johnson & Johnson Inc., Terumo Corporation, B. Braun,, Melsungen AG, Integra LifeSciences Corporation here

News-ID: 3582410 • Views:

More Releases from DataM intelligence 4 Market Research LLP

Quantum Computing Market to Reach US$ 8,788.8 Million by 2031 | Key Companies: IBM Quantum, Google, Honeywell, Rigetti, IonQ, Microsoft, D-Wave, Zapata Computing
Quantum Computing Market to Reach US$ 8,788.8 Million by 2031 | Key Companies: I …
Market Overview: The Global Quantum Computing Market reached US$ 650.1 million in 2022 and is projected to reach US$ 8,788.8 million by 2031, registering a robust CAGR of 38.9% during the forecast period 2024-2031. Quantum computing is rapidly gaining adoption across multiple industries due to its potential to perform complex calculations far beyond the capabilities of classical computers. Sectors such as logistics, materials science, and pharmaceuticals are leveraging quantum computing to
Quantum Sensors Market to Reach US$2,507.99 Million by 2032 | CAGR 15.9% | North America Leads with 40% Share | Key Players: LI-COR, Robert Bosch, Campbell Scientific, OTT HydroMet, AOSense
Quantum Sensors Market to Reach US$2,507.99 Million by 2032 | CAGR 15.9% | North …
Market Overview: The global quantum sensors market reached US$672.54 million in 2023 and increased to US$770.30 million in 2024. It is expected to surge to US$2,507.99 million by 2032, growing at a robust CAGR of 15.9% during the forecast period from 2025 to 2032. The market growth is driven by quantum sensing becoming the first commercially deployable quantum technology, with strong support from national programs in the US, Europe, China, Australia,
Early Toxicity Testing Market to Grow at 9.6% CAGR by 2031 | North America Leads with 40% Share | Key Players: Agilent, Bruker, Eurofins, GE Healthcare, Thermo Fisher, Envigo, Merck, WuXi AppTec
Early Toxicity Testing Market to Grow at 9.6% CAGR by 2031 | North America Leads …
Market Overview: The Early Toxicity Testing Market is projected to grow at a CAGR of 9.6% during the forecast period 2024-2031. Toxicity refers to the degree to which a substance can harm living organisms. In the development of new drugs, understanding the potential harmful effects of chemical compounds on biological systems is essential to identify viable therapeutic candidates. Early toxicity testing is conducted during the pre-clinical phase of drug development, serving
United States Oilseed Crop Protection Chemicals Market to Grow at 3.9% CAGR by 2031 | Asia-Pacific Leads with 39% Share | Key Players: Bayer, ADAMA, Syngenta, FMC, Nufarm, UPL
United States Oilseed Crop Protection Chemicals Market to Grow at 3.9% CAGR by 2 …
Market Overview: The Global Oilseed Crop Protection Chemicals Market is projected to grow at a high CAGR of 3.9% during the forecast period (2024-2031). Crop protection chemicals including insecticides, herbicides, and fungicides play a critical role in minimizing yield losses caused by pests, diseases, and weeds. According to the Royal Society of Chemistry, more than 800 chemically active ingredients are registered globally for crop protection use, emphasizing the scale and diversity

All 5 Releases


More Releases for Neurovascular

Emerging Trends Influencing The Growth Of The Neurovascular Catheters Market:Inn …
The Neurovascular Catheters Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Neurovascular Catheters Market Size Expected to Be by 2034? The Neurovascular Catheters Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.
Top Factor Driving Neurovascular Embolization Devices Market Growth in 2025: Ris …
What combination of drivers is leading to accelerated growth in the neurovascular embolization devices market? The rise in the prevalence of hemorrhages is expected to drive the neurovascular embolization devices market. Hemorrhages, caused by factors such as hypertension and anticoagulant medications, are treated using neurovascular embolization devices, which block abnormal blood vessels to reduce bleeding and prevent further brain damage. In February 2024, research by King's College London indicated a projected
Exploring the Neurovascular Catheters Market: Innovative Approaches to Neurovasc …
Allied Market Research Analyst have added a new research study on Title Neurovascular Catheters Market, Global Outlook and Forecast 2023-2030 with detailed information & Key Players Such as Zeus Industrial Products, Stryker, Biomerics, Integra Life Sciences, Concentric Medical, DePuy Synthes, Medtronic, RAUMEDIC, Johnson and Johnson, Integer Holdings Corporation. The Study provides in-depth comprehensive analysis includes Clear Market definitions, classifications, manufacturing processes, cost structures, development policies and plans. The facts and
Neurovascular Devices industry expected to hit a valuation of US$ 7 billion till …
The global 𝐍𝐞𝐮𝐫𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 market is estimated to attain a valuation of US$ 7 Bn by the end of 2033, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 7.6% during the forecast period, 2023 - 2033. The key objective of the TMR report is to offer a complete assessment of the global market including major leading
Brain Aneurysm Treatment - Modern Neurovascular Techniques
Brain aneurysm is a development of bulge in brain vessels. This bulging puts pressure on the nerves or brain tissues. This bulge may rupture or burse and can cause brain hemorrhage, which can cause death of the patient. Get PDF Brochure of Research Study @ https://bit.ly/2zir2hL Certain factors such as genetic conditions, arteriovenous malformations, untreated high blood pressure, and smoking are responsible to cause brain aneurysm. The global brain aneurysm treatment market
Neurovascular Devices Market: Opportunities and Challenges
The Neurovascular Devices Market is expected to reach USD 2.62 billion by 2021 from USD 1.74 billion in 2016, at a CAGR of 8.6% from 2016 to 2021. Increasing research activities in the field of neurovascular therapies Neurovascular devices are witnessing a growing demand among the major stakeholders globally, due to increasing clinical research activities in the field of neurovascular therapies, which offer credible clinical data related to their safety & efficacy